AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering ...

April 20 (Reuters) - AstraZeneca said on Monday its experimental treatment tozorakimab showed a "meaningful reduction" in ...

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent airflow limitation and chronic inflammation. Beyond its primary pulmonary manifestations, ...

A third consecutive phase III success for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) tozorakimab in chronic obstructive pulmonary ...

In the spring, patients with chronic obstructive pulmonary disease (COPD) may develop a common acute respiratory viral infection (ARVI) into a serious exacerbation. On April 20, Sergey Avdeev, MD, ...

Chronic obstructive pulmonary disease (COPD) is a major respiratory condition that impairs airflow and has widespread systemic implications. A growing body of research indicates that this disorder is ...

While chronic obstructive pulmonary disease can make exercise more challenging, regular physical activity may actually improve your symptoms and make it easier to perform everyday tasks. In addition ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

TARRYTOWN, N.Y. and PARIS, May 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

Adding as little as 1,700 to 5,500 steps per day can offset the risk of a list of chronic diseases—including obesity, diabetes and sleep apnea—according to a new study from a corresponding author with ...